6 employees
Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.
2018
$4M
from 4 investors over 4 rounds
Synerkine Pharma raised $4M on December 16, 2021
Investors: Thuja Capital, Flerie Invest and Utrecht Holdings (Universiteit Utrecht)
Synerkine Pharma raised $3.7M on March 25, 2019
Investors: Thuja Capital